Schedule 13D ownership disclosure

MERSANA THERAPEUTICS INC

Common Stock, par value $0.0001 per share · CUSIP: 59045L205

Event date: 2025-11-12

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Bain Capital Life Sciences Fund II, L.P.Reported CIK 0001773187

    Shares: 131,776 · Class: 2.6%

  • BCIP Life Sciences Associates, LPReported CIK 0001702921

    Shares: 16,049 · Class: 0.3%

  • BCLS II Investco, LPReported CIK 0001818893

    Shares: 198,720 · Class: 4.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-25-280672
Form type
SCHEDULE 13D/A
Filer
Bain Capital Life Sciences Fund II, L.P.
CIK
CIK 1773187
Filed
Nov 13, 2025
Reporting period
Nov 12, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub